Boon P, Vonck K, Van Walleghem P, D'Havé M, Goossens L, Vandekerckhove T, Caemaert J, De Reuck J
Reference Center for Refractory Epilepsy, Department of Neurology, Ghent University Hospital, Ghent, Belgium.
J Clin Neurophysiol. 2001 Sep;18(5):402-7. doi: 10.1097/00004691-200109000-00003.
Vagus nerve stimulation (VNS) is an effective alternative treatment for patients with refractory epilepsy. The generator produces intermittent stimulation trains and does not require patient intervention. Using currently available technology, continuous stimulation is incompatible with a reasonable battery life. Because earlier studies have demonstrated the persistence of a stimulation effect after discontinuation of the stimulation train, we intended to evaluate the clinical efficacy of VNS in both the programmed intermittent stimulation mode and the magnet stimulation mode. Patients, companions, and caregivers were instructed on how to administer additional stimulation trains when an aura or a seizure onset occurred. We assumed that patients or caregivers could recognize habitual seizures and were able to evaluate sudden interruption of these seizures. During a mean follow-up of 35 months, 46% of patients became responders, with a reduction in seizure frequency of more than 50%. Twenty-nine percent of patients stopped having convulsive seizures. In two thirds of patients who were able to self-administer or receive additional magnet stimulation, seizures could be interrupted consistently or occasionally. More than half of the patients who reported a positive effect of magnet stimulation became responders. Only three patients were able to use the magnet themselves. In most cases, support from caregivers was necessary. This study is the first to document the efficacy of magnet-induced VNS in a larger patient population during long-term follow-up. The magnet is a useful tool that provides patients who are treated with VNS and mainly caregivers of such patients with an additional means of controlling seizures. To further confirm the self-reported results from our patients, additional studies comparing programmed stimulation and magnet-induced stimulation during monitoring conditions are needed.
迷走神经刺激(VNS)是难治性癫痫患者的一种有效替代治疗方法。发生器产生间歇性刺激序列,无需患者干预。使用现有技术,持续刺激与合理的电池寿命不相容。由于早期研究表明在刺激序列停止后刺激效果仍持续存在,我们旨在评估VNS在程控间歇性刺激模式和磁刺激模式下的临床疗效。指导患者、陪伴者和护理人员在先兆或癫痫发作开始时如何给予额外的刺激序列。我们假设患者或护理人员能够识别习惯性癫痫发作,并能够评估这些发作的突然中断情况。在平均35个月的随访期间,46%的患者成为反应者,癫痫发作频率降低超过50%。29%的患者不再有惊厥性发作。在能够自行给予或接受额外磁刺激的患者中,三分之二的患者癫痫发作能够持续或偶尔被中断。报告磁刺激有积极效果的患者中,超过一半成为反应者。只有三名患者能够自己使用磁体。在大多数情况下,需要护理人员的支持。这项研究是首次在较大规模患者群体的长期随访中记录磁诱导VNS的疗效。磁体是一种有用的工具,为接受VNS治疗的患者以及此类患者的主要护理人员提供了一种额外的控制癫痫发作的手段。为了进一步证实我们患者的自我报告结果,需要在监测条件下进行额外的研究来比较程控刺激和磁诱导刺激。